Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

ATBAŞOĞLU, EŞREF; Gumus-Akay, Guvem; Guloksuz, Sinan; SAKA, MERAM; Ucok, Vehbi; ALPTEKİN, KÖKSAL; GÜLLÜ, SEVİM; van Os, Jim

doi:10.1007/s00213-017-4818-z

Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

ATBAŞOĞLU E. C., Gumus-Akay G., Guloksuz S., SAKA M. C., Ucok A., ALPTEKİN K., ...More

PSYCHOPHARMACOLOGY, vol.235, no.4, pp.1029-1039, 2018 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 235 Issue: 4
Publication Date: 2018
Doi Number: 10.1007/s00213-017-4818-z
Journal Name: PSYCHOPHARMACOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1029-1039
Istanbul University Affiliated: Yes

Abstract

Type 2 diabetes (T2D) is more frequent in schizophrenia (Sz) than in the general population. This association is partly accounted for by shared susceptibility genetic variants.